Inteligex
Toronto, Ontario, Canada
About Inteligex
Inteligex is developing proprietary stem cell-based therapeutics to restore function in patients with spinal cord injury’ a devastating condition for which there is no effective therapy ’ and for other diseases of the Central Nervous System. Successful outcomes from the development program would position Inteligex as the first in the world with a treatment affecting hundreds of thousand patients worldwide.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Non-Equity Assistance (Jan 2021)
- Website: inteligex.ca
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/inteligex-2458428 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.